Table 1.

Baseline Patient Demographics and Characteristics

PlaceboSumatriptan NS (mg/Dose)
51020Total
Patients,n 131128133118510
Age, y
 Mean (SD)14.2 (1.6)14.1 (1.7)14.0 (1.6)14.0 (1.6)14.1 (1.6)
Gender, %
 Males/females50/5051/4945/5548/5249/51
Migraine type, %
 Without aura7270737572
 With aura1311 91412
 Both1520181116
Pain severity, %
 Moderate6562657065
 Severe3538353035
Time to treatment, h
 Mean (SD)1.70 (1.6)2.09 (2.0)1.90 (1.7)1.96 (2.3)1.91 (1.9)
Previous 5HT1 agonist Use, %
 None5863615659
 Sumatriptan oral (100 mg) 0<1 0 0<1
 Sumatriptan oral (50 mg) 813111211
 Sumatriptan oral (25 mg)2719272725
 Sumatriptan SC 6 5 6 8 6
 Sumatriptan NS 2 5 3 3 3
 Other 5HT1agonist 8 7 4 8 7
  • SD indicates standard deviation; SC, subcutaneous.